Adjupharm GmbH

What Adjupharm GmbH does

Adjupharm GmbH is a German full-service pharmaceutical contract manufacturer founded in 1991 in Bad Oldesloe, Schleswig-Holstein. With a headcount of seven employees, the company operates an EU-GMP Class D cleanroom, advanced air handling systems, and a secure BtM (controlled substance) storage bunker with capacity for up to 1.5 tonnes of cannabis flowers, plus primary and secondary packaging lines. Since 2017–2018, Adjupharm has pivoted into medical cannabis and now offers contract manufacturing (Lohnherstellung), wholesale distribution of medical cannabis and vaporizers (since 2007 as wholesaler and 2018 with BtM license), white-label production, temperature- and humidity-controlled storage and logistics, regulatory consulting, quality management, and bulk-to-dose repackaging of cannabis products.

The company holds a stacked portfolio of regulatory permits including Arzneimittel-Herstellungserlaubnis (1991), GMP, AMWHV compliance, Großhandels-Erlaubnis (2007), GDP (2013), BtM-Erlaubnis (2018), EU cannabis import (2019), non-EU cannabis import (2021), and cannabis repackaging (2022). It serves German pharmacies, pharmaceutical wholesalers, medical cannabis companies, and dietary supplement manufacturers through direct B2B sales, with a professional channel via the DocCheck Fachkreis portal. Adjupharm became a subsidiary of International Medical Cannabis (IMC) in 2019, giving it access to Israeli and Canadian cannabis expertise and supply chains. The revenue model blends project-based contract manufacturing fees, wholesale margins on distributed cannabis products, and value-added services (storage, regulatory consulting, white-label setup), with pricing quoted per-project rather than on a published schedule.

Name

Adjupharm GmbH

Legal name

adjupharm GmbH

Website

https://adjupharm.de

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

1–10 employees

Short description

Adjupharm GmbH is a German pharmaceutical contract manufacturer and medical cannabis wholesaler in Bad Oldesloe, serving pharmacies and cannabis companies with GMP-compliant manufacturing, storage, packaging, and regulatory consulting. Since 2019 it has operated as a subsidiary of IMC.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Cannabis Wholesale Distribution (Flower, Extracts, Edibles) (CRAOAIAF)

akta.pro secondary industry

Cannabis Accessories & Ancillary Products Wholesale (Vapes, Packaging, Hardware) (CRAOAIAH)

Keywords

• Pharmaceutical contract manufacturing
• Medical cannabis wholesale
• Cannabis contract manufacturing
• Pharmaceutical toll manufacturing
• GMP-compliant manufacturing

Headquarters

HQ city

Bad Oldesloe

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing (Lohnherstellung): Full-service contract manufacturing for pharmaceutical and dietary supplement industries. Services include white label production, bulk filling, labeling, secondary packaging, and quality release.
2. Medical Cannabis Wholesale: Wholesale distribution of medical cannabis products and accessories (vaporizers) to pharmacies and pharmaceutical wholesalers since 2007, with specialized import capabilities since 2021.
3. Own Products: Sale of proprietary products including the Wulf-Rabe biological products line (acquired 2011) and own-manufactured dietary supplements.
4. Regulatory & Consulting Services: Regulatory consulting, quality management support, license acquisition assistance for controlled substances, irradiation permits, and import permits.
5. Storage & Logistics Services: Temperature and humidity controlled storage in secure BtM bunkers, logistics, returns management, and supply chain management services.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Adjupharm GmbH provides full-service pharmaceutical contract manufacturing (Lohnherstellung) and wholesale distribution, with a specialized focus on medical cannabis since 2017. Core offerings include contract manufacturing for pharmaceutical and dietary supplement products, white-label product development, primary and secondary packaging, repackaging of medical cannabis, temperature- and humidity-controlled BtM bunker storage with logistics, and regulatory/quality management consulting supporting BtM, GMP, GDP, and cannabis import licensing. The company distributes its own medical cannabis portfolio as well as partner brands (IMC, Bedrocan) and the acquired Wulf Rabe homeopathic line to German pharmacies and pharmaceutical wholesalers.

Product overview

Adjupharm GmbH is a full-service pharmaceutical contract manufacturer and wholesale distributor founded in 1991, specializing in medical cannabis since 2018. The company operates a platform-based model offering core medical cannabis products (including IMC and Bedrocan brands), contract manufacturing services, and value-added modules including white labeling, storage/logistics, regulatory/quality management, consulting, and repackaging services. The company also acquired the Wulf Rabe homeopathic product line in 2011, representing a diversified portfolio spanning pharmaceutical manufacturing, dietary supplements, and medical cannabis products. The offering architecture combines product sales (cannabis, accessories, homeopathic remedies) with comprehensive service modules enabling customers to bring cannabis projects from concept through market launch.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Cannabis (Medizinisches Cannabis)

Quantifiable outcome

• Over 30 years of pharmaceutical industry experience
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• IMC - International Medical CannabiscoreStrategic or Co-development Partner · 1 January 2019Adjupharm became a subsidiary of International Medical Cannabis (IMC) in 2019. IMC originates from Israel, the birthplace of medical cannabis. This partnership brings together innovation, extensive cannabis industry expertise, cutting-edge technologies, and reliability in supply. IMC cannabis products represent the combined know-how of Israel, Canada, and Germany.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Demecan GmbH: German vertically integrated medical cannabis company with own cultivation, processing, and wholesale distribution to pharmacies. Comparable as a domestic competitor in GMP-contract manufacturing and wholesale of medical cannabis flowers and extracts to the German pharmacy channel.
• Cannamedical Pharma GmbH: German medical cannabis importer and wholesaler supplying pharmacies with cannabis flowers, extracts, and pharmaceutical-grade products. Comparable as a pharmacy-focused wholesale distributor with EU-GMP-compliant supply chain operations.
• Sanity Group GmbH: Berlin-based European cannabis company with pharmaceutical manufacturing and distribution operations in Germany. Comparable in combining EU-GMP processing, cannabis imports, and pharmacy distribution.
• Cantourage GmbH: Berlin-based medical cannabis company distributing cannabis flowers and extracts from international producers to German pharmacies via a toll-manufacturing model. Directly comparable as a B2B importer and contract manufacturer serving the same pharmacy and wholesaler customer base.
• Cansativa GmbH: German cannabis B2B platform and wholesaler distributing medical cannabis to pharmacies. Comparable as a domestic wholesale distribution peer operating in the same regulatory and pharmacy-customer ecosystem.

Broad incumbents

• Bedrocan International: Dutch licensed producer of standardized medicinal cannabis with long-standing presence in the German market. Comparable as an upstream supplier whose products Adjupharm already distributes; a potential vertical-integration risk for Adjupharm's wholesale business.
• Aurora Cannabis: Canadian licensed producer with established German distribution via Eurox Pharma. Comparable as an international cannabis supplier competing for the same German pharmacy channel through EU-GMP imports.
• Tilray Brands: Global cannabis major with German medical cannabis operations including cultivation, import, and distribution. Comparable as a large-scale, well-capitalized competitor with overlapping wholesale and pharmacy-supply capabilities in Germany.

Regional players

• Eurox Pharma GmbH: German medical cannabis company focused on EU-GMP-certified cannabis products and pharmacy distribution. Comparable as a regional pharmaceutical-grade cannabis manufacturer competing for the same German B2B customers.
• Avextra Pharma GmbH: German medical cannabis company focused on EU-GMP manufacturing and pharmacy distribution. Comparable as a regional GMP manufacturer-wholesaler with similar regulatory positioning and customer base in Germany.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/adjupharm-gmbh

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adjupharm GmbH